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Abstract
Background—Previous work has suggested significant associations between various
psychological symptoms (e.g. depression, anxiety, anger, alcohol abuse) and hypertension.
However, the presence and extent of associations between common mental disorders and
subsequent adult onset of hypertension remains unclear. Further, there is little data available on
how such associations vary by gender or over life course.
Methods—Data from the World Mental Health Surveys (comprising 19 countries, and 52,095
adults) were used. Survival analyses estimated associations between first onset of common mental
disorders and subsequent onset of hypertension, with and without psychiatric comorbidity
adjustment. Variations in the strength of associations by gender and by life course stage of onset
of both the mental disorder and hypertension were investigated.
Results—After psychiatric comorbidity adjustment, depression, panic disorder, social phobia,
specific phobia, binge eating disorder, bulimia nervosa, alcohol abuse, and drug abuse were
significantly associated with subsequent diagnosis of hypertension (with ORs ranging from 1.1 to
1.6). Number of lifetime mental disorders was associated with subsequent hypertension in a dose-
response fashion. For social phobia and alcohol abuse, associations with hypertension were
stronger for males than females. For panic disorder, the association with hypertension was
particularly apparent in earlier onset hypertension.
Conclusions—Depression, anxiety, impulsive eating disorders, and substance use disorders
disorders were significantly associated with the subsequent diagnosis of hypertension. These data
underscore the importance of early detection of mental disorders, and of physical health
monitoring in people with these conditions..
Keywords
Hypertension; common mental disorders; World Mental Health Surveys
INTRODUCTION
Previous work has suggested significant associations between hypertension and
psychological symptoms such as depression, anxiety, and anger (1,2). The existence of such
associations would be consistent with work indicating that such symptoms are accompanied
by alterations in peripheral and central neuro-endocrine systems, or may have a range of
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behavioral correlates, which may in turn have persistent adverse effects on physical health
(3). At the same time, there is little prospective data directly demonstrating a link between
alterations in neurophysiology or behavior and subsequent hypertension, and it has also been
suggested that being labeled as hypertensive itself leads to psychological symptoms (4).
Indeed, the presence and extent of associations between onset of common mental disorders
and subsequent adult onset hypertension remains unclear. Much of the literature in this area
has employed symptom screening scales, which may not discriminate well between different
negative emotions, and little of the literature in this area has assessed common mental
disorders (1,2). Much work has focused on specific psychological domains rather than on
the relative contributions of a range of symptoms or disorders, and no data are available on
the effects of mental disorder comorbidity on subsequent hypertension. Further, there is little
if any work examining the possibility that such associations may vary by gender or over the
life course.
Assessing the nature of the associations between onset of common mental disorders and
subsequent hypertension is important for several reasons. First, there is ongoing
neuroscientific and behavioral interest in the potential mechanisms accounting for the
adverse effects of psychological symptoms and mental disorders on physical health (5;6).
Second, given that common mental disorders are highly prevalent, often begin early in life,
and are treatable (7), an association between such conditions and subsequent hypertension
would have important public health implications.
The cross-national World Mental Health Surveys (WMHS) provide a valuable dataset for
addressing questions about the presence and extent of associations between onset of
common mental disorders and subsequent chronic medical conditions. In these population-
based surveys, individuals from countries around the world have been assessed for lifetime
history of a wide range of common mental disorders, as well as for self-reported physician’s
diagnosis of chronic medical conditions including hypertension (8). Although the surveys
are cross-section in design, information on the time of onset of these conditions was
collected. Here we examine the association between temporally prior common mental
disorders and subsequent onset of hypertension in countries participating in the WMHS,
using survival analysis methods.
METHOD
Samples and Procedures
Data are from 19 of the WMH surveys: Colombia, Mexico, Peru, United States, Shenzhen
(China), Japan, New Zealand, Belgium, France, Germany, Italy, the Netherlands, Romania,
Spain, Portugal, Israel, Iraq, Northern Ireland, Poland (see Table 1). A stratified multi-stage
clustered area probability sampling strategy was used to select adult respondents (18 years+)
in most WMH countries. These surveys were based on nationally representative household
samples, except for Colombia, Mexico and Shenzhen, which were based on representative
household samples in urbanized areas.
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In most countries, internal sub sampling was used to reduce respondent burden and average
interview time by dividing the interview, an expanded version of the WHO-Composite
International Diagnostic Interview (CIDI 3.0) into two parts. All respondents completed Part
1 which included the core diagnostic assessment of most common mental disorders. All Part
1 respondents who met lifetime criteria for any core mental disorder and a probability
sample of other respondents were administered Part 2 which assessed physical conditions
and collected a range of other information including socio-demographic data. Part 2
respondents were weighted by the inverse of their probability of selection to adjust for
differential sampling. Analyses in this paper are based on the weighted Part 2 sub sample
(n= 52,095). Part 2 respondents were weighted by the inverse of their probability of
selection for Part 2 of the interview to adjust for differential sampling. In other words,
people with mental disorders were over sampled in the Part 2 sub sample in order to boost
sample size, but then down weighted in analyses; while people without mental disorders
were under sampled in the Part 2 sub sample, but then up weighted in analyses. The net
effect of the weighting procedures is an unbiased sample. Additional weights were used to
adjust for differential probabilities of selection within households, to adjust for non-
response, and to match the samples to population sociodemographic distributions. Measures
taken to ensure interviewer and data accuracy and cross-national consistency are described
in detail elsewhere (9). All respondents provided informed consent and procedures for
protecting respondents’ identity were approved and monitored for compliance by the
Institutional Review Boards in each country.
Measures
Mental disorders—All surveys used the WMH survey version of the WHO Composite
International Diagnostic Interview (now CIDI 3.0), a fully structured interview, to assess
lifetime diagnosis of mental disorders. Disorders were assessed using the definitions and
criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)
(10). The mental disorders assessed for in this paper include anxiety and related disorders
(panic disorder, agoraphobia without panic, specific phobia, social phobia, post-traumatic
stress disorder, generalized anxiety disorder, obsessive compulsive disorder); mood
disorders (major depressive disorder/dysthymia, bipolar disorders I, II and broad); substance
use disorders (alcohol abuse and dependence, drug abuse and dependence); and impulse
control disorders (intermittent explosive disorder, bulimia nervosa and binge eating
disorder). The different impulse control disorders are classified in different sections of
DSM-IV; intermittent explosive disorder is described in the section on impulse control
disorders not elsewhere classified, while the impulsive eating disorders, bulimia nervosa and
binge eating disorder, are found in the chapter on eating disorders. CIDI organic exclusion
rules were applied in making diagnoses. Clinical reappraisal studies conducted in some of
the WMH countries indicate that lifetime diagnoses of anxiety, mood and substance use
disorders based on the CIDI have generally good concordance with diagnoses based on
blinded clinical interviews (11).
Hypertension status—In a series of questions adapted from the U.S Health Interview
Survey, respondents were asked about the lifetime presence of selected chronic conditions.
Respondents were asked: “Did a doctor or other health professional ever tell you that you
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had any of the following illnesses….high blood pressure?” If respondents endorsed this
question they were classified as having a history of hypertension for these analyses.
Respondents were also asked how old they were when they were first diagnosed with high
blood pressure. This year is referred to herein as the age of onset of hypertension, although it
is recognized that the underlying pathophysiology of hypertension develops over many
years. Only adult-onset hypertension (onsets age 21+) were investigated in this paper.
Statistical Analysis
Discrete-time survival analyses (12) with person-year as the unit of analysis were used to
test sequential associations between first onset of mental disorders and the subsequent onset
of hypertension. For these analyses a person-year data set was created in which each year in
the life of each respondent up to and including the age of onset of hypertension or their age
at interview (whichever came first) was treated as a separate observational record, with the
year of hypertension onset coded 1 and earlier years coded 0 on a dichotomous outcome
variable. The small number of people who reported hypertension onset before age 21 were
excluded from analysis. Mental disorder predictors were coded 1 from the year after first
onset of each individual mental disorder. This time lag of 1 year in the coding of the
predictors ensured that in cases where the first onset of a mental disorder and of
hypertension occurred in the same year, the mental disorder would not count as a predictor.
Only person-years up to the diagnosis of hypertension were analyzed so that only mental
disorder episodes occurring prior to the onset of hypertension were included in the predictor
set. Logistic regression analysis were used to analyze these data with the survival
coefficients presented as odds ratios, indicating the relative odds of hypertension onset in a
given year for a person with a prior history of mental disorder compared to a person without
that mental disorder.
A series of bivariate and multivariate models were developed including the predictor mental
disorder plus control variables. Models control for person-years, countries, gender, current
age, and in the multivariate models, other mental disorders. Bivariate models investigated
association of specific mental disorders with subsequent hypertension onset. The next
model, a multivariate model, estimated the associations of each mental disorder with
hypertension onset adjusting for mental disorder comorbidity (that is, for other mental
disorders occurring at any stage prior to the onset of hypertension). A second multivariate
model included a series of predictor variables for number of mental disorders (e.g., one such
variable for respondents who experienced exactly one mental disorder, another for
respondents who experienced exactly two mental disorders, and so on), as well as the
control variables. Other more complex non additive multivariate models were also run, for
example including both type and number of mental disorders, but model fit statistics did not
indicate a better fit for the data, so the simpler models are reported here.
Our general approach was to not control for covariates that could be on the causal pathway
between mental disorders and subsequent hypertension. However, we recognize that these
variables may also confound associations so we re-estimated the multivariate model with
adjustment for history of smoking (ever/never) and educational attainment. This made
virtually no difference to associations (all previously significant associations remained
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significant, with the one exception, namely that between bulimia nervosa and hypertension,
and none reduced in magnitude) so we report the results from the model unadjusted for
smoking and education in this paper.
We examined life course variation in two ways. First, we examined whether early versus
late onset mental disorders differed significantly in their associations with hypertension
through creation of mental disorder-specific dummy variables for early onset mental
disorder (<= 21 years) and late onset disorder (>21 years) (see table footnotes for model
specification). Second, we assessed whether associations varied by when in the life course
hypertension was diagnosed by including interaction terms between person-years (coded as
a continuous variable) and each type of mental disorder in the multivariate type model.
Gender differences were examined by including interaction terms between gender and each
mental disorder in the multivariate type model.
Our earlier studies of concurrent mental-physical comorbidity in the WMH surveys found
that these associations are generally consistent cross-nationally, despite varying prevalence
of mental disorder and physical conditions (13). All analyses for this paper were therefore
run on the pooled cross-national dataset. We ran sensitivity analyses to test whether the
associations between number of disorders and hypertension held in both lower and higher
income countries, and we found that they did, but were slightly (but significantly) stronger
in lower income countries (data not shown, available on request). As the WMH data are both
clustered and weighted, the design-based Taylor series linearization implemented in version
10 of the SUDAAN software system was used to estimate standard errors and evaluate the
statistical significance of coefficients (14).
RESULTS
Descriptive
The survey characteristics are shown in Table 1 together with information about the number
of survey respondents reporting a history of hypertension (n=8422).
Type and number of mental disorders as predictors of hypertension onset
The associations between individual mental disorders and subsequent hypertension onset
were investigated in a series of bivariate models (i.e., only one mental disorder considered at
a time). In the results presented in Table 2, it is apparent that all but one type of mental
disorder were found to predict adult hypertension onset with odds ratios (ORs) ranging
between 1.4 and 2.5. The median number of years between onset of the predictor mental
disorder and hypertension onset ranged from 11.7 (for bipolar disorder) to 34.2 (for specific
phobia) (data not shown).
When lifetime comorbidity (that is, up until the age of onset of hypertension) was taken into
account in the multivariate models, the magnitude of associations diminished slightly. The
mental disorders that remained significant in the multivariate models were depression/
dysthymia, panic disorder, social phobia, specific phobia, agoraphobia, binge eating
disorder, bulimia nervosa, alcohol abuse and drug abuse, with ORs from 1.1 to 1.6. The
global chi square test for the joint effect of all mental disorders was significant (χ162=
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304.7, p <=0.05) and the test for variation in ORs indicates that we can reject the hypothesis
that the ORs are the same for all the mental disorders (χ152= 28.2, p <=0.05). This latter test
allows more confident interpretation of the statistically significant mental disorders as
having specific associations with hypertension onset (rather than indicating a generalized
link between psychopathology and hypertension).
The results from a multivariate model that considered only number of mental disorders (i.e.,
not including information about type) are presented in the final column of data in Table 2.
This suggests a dose-response relationship between the number of mental disorders
experienced over the life course and subsequent onset of hypertension, with ORs ranging
from 1.4 for one mental disorder to 2.5 for 5+ mental disorders. The global chi square test
for the joint effect of the number of mental disorders was significant (χ52= 212.6, p
<=0.05). This model was a better fit for the data than either the multivariate type model just
presented or a more complex model including information about number and type (model
fitting results available on request).
Noting that the prevalence of hypertension was surprisingly low in our Chinese sample,
were-analysed associations between individual mental disorders and subsequent
hypertension onset, but with this sample excluded (data not shown). We found an increase in
the strength of the associations, as reflected in the global chi square test for the joint effect
of all mental disorders (χ162= 3154.7, p <=0.05), the test for variation in ORs (χ152= 29.0, p
<=0.05), and the global chi square test for the joint of effect of number of disorders (χ52=
219.2, p <=0.05).
Timing of mental disorder onset (early versus late onset)
We investigated whether early onset mental disorders (first onset occurring prior to the age
of 21) were more or less strongly associated with hypertension onset than later onset mental
disorders (Table 3). The first two columns of data in the table present the results from the
bivariate models where early onset and late onset variants of each mental disorder were both
included in the one model predicting subsequent onset of hypertension, with the usual
control variables but with no adjustment for other mental disorders. Some early onset mental
disorders, such as panic disorder, agoraphobia, and drug dependence had quantitatively
larger associations with hypertension than their later onset counterparts, with the reverse
being true for bulimia nervosa and alcohol dependence. However, in the second set of
models which tested whether these apparent differences were statistically significant after
accounting for the effect of having the mental disorder at all, no significant differences
between early and late onset disorders were found in either the bivariate or multivariate
models, with one exception, namely that late onset depression/dysthymia (OR=1.3, 95% CI
1.2–1.4) had a higher association than early onset depression/dysthymia (OR=1.1, 95% CI
0.9–1.2) with hypertension in the multivariate model. Taken together, therefore, variation in
the timing of the mental disorder predictor does not significantly affect the strength of
association with subsequent hypertension onset.
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Gender differences
There were few significant interactions of gender with any of the mental disorders in
associations with hypertension onset (results not shown, available on request), with the
exceptions of social phobia and in alcohol abuse (OR=1.3 in males and OR=1.0 in females
for social phobia, OR = 1.5 in males and OR = 1.1 in females for alcohol abuse, when the
multivariate models were employed).
Variation across the life course (timing of hypertension onset)
We then examined whether associations between mental disorders and hypertension onset
varied as a function of when in the life course the hypertension onset occurred. These
analyses were undertaken in multivariate models adjusting for other mental disorders. The
interaction tests between the majority (11/16) of mental disorders and person year were not
significant, indicating that for these disorders variation in the timing of hypertension onset
makes little difference to the strength of associations. For depression, bipolar disorder, panic
disorder, posttraumatic stress disorder, and alcohol dependence, however, there was a
significant negative interaction with person year, shown in the first 3 data columns in Table
4. To illustrate the nature of the interaction the person year dataset was then stratified into
quartiles of the hypertension onset distribution and the multivariate modelsre-estimated in
each of these quartiles. These results, shown in the remainder of Table 4, only partially
support the possibility that the association with hypertension onset is strongest when the
hypertension occurred at any particular stage of life. In panic disorder, however, the
association between panic disorder and subsequent hypertension is significantly elevated
(OR 1.5) for the younger person year groups (up to age 40) but not for those in other age
groups. This may be an important qualifying result of the main effect for panic disorder
averaged across all person years presented in Table 2.
DISCUSSION
Several limitations of the current study deserve emphasis. First, retrospective assessment of
mental disorders may lead to under-estimations of prevalence, and may also be associated
with inaccuracies in age of onset timing (15). Second, there was no clinical data to validate
the diagnosis of hypertension, or to characterize fully its duration, severity, and sequelae.
Nevertheless, self-reported hypertension is moderately associated with objective data on
hypertensive status (16 (16,17). Estimates of sensitivity of self-report of hypertension range
from 64% to 91% in several Western countries, although these may be lower in other
locations (18) (as is apparent also in our own data). Further, while depression has been
found to increase bias towards self-report of physical symptoms, it has not been found to
increase bias towards self-report of diagnosed physical conditions (19).
Taken together, then, misclassification of individuals with regard to the predictor (i.e,
common mental disorders) and outcome (e.g., adult onset of hypertension) in the World
Mental Health Surveys is likely to be largely non-differential. As a consequence, the
strength of the associations between mental disorders and subsequent hypertension reported
here, are likely to be under-estimates. Thus, for example, a re-analysis excluding the
Chinese sample, in which there was very low prevalence of hypertension, yielded an
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increased strength of association between mental disorders and hypertension. An additional
factor contributing to the likely conservative bias here is that the study was only conducted
among hypertension (and mental disorder) survivors. It is possible that some of those
individuals most adversely affected by an association between common mental disorders
and subsequent hypertension are under-represented in the sample due to premature
mortality.
Epidemiological studies of hypertension are rarely able to obtain detailed data on common
mental disorders, and the current study has several strengths, including the large number of
respondents from across the globe, and the rigorous assessment of a full range of common
mental disorders. Indeed, this is the first study on the association of common mental
disorders with hypertension to include a wide range of disorders and to adjust for
comorbidity. It is therefore of interest that we found a modest but significant association
between the onset of several mood, anxiety, impulse-control and substance disorders with
subsequent hypertension. These data are consistent with multiple reports that have focused
on the association between single psychological domains and hypertension (1,2).
The fact that we found both major depression and anxiety disorders to be significantly
associated with hypertension after mutual adjustment has implications for possible
mechanisms. The majority of prior studies on this topic have focused on a single symptom
domain or a narrow set of mental disorders; this focus can lead to mechanistic explanations
that are overly specific to the variables studied. The findings here suggest that when
considering how mental disorders may lead to hypertension, it may be useful to focus on
potential causal mechanisms that mood and anxiety disorders have in common; these
include altered sleep patterns, sympathoadrenal hyper-reactivity, various neurotransmitter
abnormalities, and altered inflammatory processes (20,21). At the same time, it is possible
that various common factors, such as exposure to childhood adversity, may partially explain
the associations between depression and anxiety disorders on the one hand, and hypertension
on the other hand (8).
Previous work on impulsive eating disorders has noted that while some individuals may
develop hypotension due to bulimia, other individuals may develop metabolic syndrome
including hypertension (21,23). Although the WMH Surveys asked about the presence of
obesity, age of onset was not assessed, so precluding an analysis of the relative timing of
obesity and hypertension. Hypertension in eating disorders may reflect a direct effect of
binge eating, perhaps due to the large amount of food ingested, although further work is
needed in order to elucidate the relevant mechanisms involved (22). It is noteworthy that
there was no association between intermittent explosive disorder and hypertension onset
after comorbidity adjustment. Indeed, previous systematic reviews investigating the
association between hostility, anger, and hypertension has emphasized that findings are far
from consistent, and that they may be influenced by multiple confounders (4).
The association between alcohol, substances and hypertension reported here has long been
recognized (23,24,25). Animal experiments done more than a century ago showed that
alcohol had vasoconstrive and vasodilatory effects, and subsequent clinical work has
suggested that regular alcohol consumption is associated with central sympathoadrenergic
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activation. A range of other mechanisms may also be relevant. Similarly, use of
sympathomimetic substances may lead to hypertension. Despite the important contributions
of both alcohol and hypertension to the global burden of disease, the population attributable
risk percentage for hypertension due to alcohol is estimated to be small (26), and this may
contribute to the failure to observe associations between alcohol and drug dependence in the
current study.
It is notable that the strength of the associations of hypertension with impulsive eating
disorders were highest, followed in turn by the associations of hypertension with substance
use disorders, and then by those of hypertension with mood and anxiety disorders. This is
the first study to examine these associations after adjustment for a full range of comorbid
mental disorders, and it is relevant to emphasize that there is some evidence of a dose-
response relationship between the number of common mental disorders and the subsequent
onset of hypertension. This finding is potentially important insofar as it identifies specific
potential intervention targets for reducing hypertension (27). At the same time it is
consistent with other publications from the WMHS which emphasize the additive effects of
comorbidity on a range of measures including psychosocial impairment as well as medical
morbidity.
In general, our results reveal few significant differences in the patterns of associations for
hypertension across gender. The finding that the association is stronger for alcohol abuse in
males is, however, noteworthy, and is consistent with previous work which has indicated
that alcohol consumption may protect against hypertension at low doses in women, but that
as in men there is a linear association between alcohol consumption and hypertension at
higher doses (23,24). This finding emphasizes the complexity of the relationships between
common mental disorders and hypertension, and the care that needs to be taken when
assessing the public health implications of findings. Speculatively, given the normative
nature of mild but not more severe social anxiety in women in some societies, an analogous
mechanism is at play in this condition.
Variation in the timing of the mental disorder predictor did not significantly affect the
strength of association with subsequent hypertension onset. Panic disorder, however, may be
more strongly associated with subsequent early onset hypertension, a finding that is
consistent with previous clinical work noting the association between panic attacks and an
immediate increase in blood pressure (28), and with ongoing neuroscientific research on
potential mechanisms which underlie this phenomenon (29,30). The lack of associations
between other disorders and hypertension and life course has implications for study design;
for example, the effects of conditions such as depression on subsequent hypertension may be
subtle compared to the effects of aging, and so may not be manifest in studies with an
average older age of participants.
Taken together, these data from the WMHS indicate modest but significant associations
between a range of common mental disorders and hypertension. This study offers new
insights into the nature of the association between common mental disorders and
hypertension including the importance of mental disorder comorbidity; the relative
magnitude of associations; and the strength of associations by gender and by life course
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stage of onset of both the mental disorder and hypertension. The data here contribute to a
growing literature on the importance of the relationship between mental disorders and
chronic physical conditions, and have clear public health import insofar as they underscore
the importance of early detection of and intervention for mental disorders, and of physical
health monitoring in people with these conditions. Although it remains to be established
whether some of these associations are causal, the finding of associations with increased risk
of hypertension in both men and women from developed and developing countries
strengthens the need for further mechanistic work in this area (30).
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